Hopp til innhold
NHI.no
Annonse
Informasjon

Prognosen ved generalisert angstlidelse

Prognosen ved generalisert angstlidelse er blant annet avhengig av om du oppsøker hjelp, og av at du blir lenge nok i behandling.

mann samtale.jpg
Behandling kan hjelpe deg å få symptomene under kontroll.

Sist oppdatert:

3. mai 2024

Innhold i artikkelen

Søk hjelp

Angstlidelser går sjelden over av seg selv. Bedre innsikt i hvordan man selv reagerer kan gi en varig bedring. Medikamenter er til hjelp for noen, men gir sjelden en varig effekt. Symptomene dine kan komme og gå. Du vil ha perioder der du er bedre, og du vil ha perioder der du er verre. Mange som sliter med en angstlidelse opplever redusert livskvalitet.

Annonse

Behandling kan bedre livskvaliteten. Det finnes gode behandlinger som kan hjelpe deg til å kontrollere dine bekymringer. Formålet med behandlingen er ikke nødvendigvis å gjøre deg helt angstfri, men heller at du skal leve bedre med din angst. Hvis du tror du har en angstlidelse, bør du søke hjelp. La ikke angstfølelsen styre livet ditt. Angst kan dessuten føre til andre problemer. Noen prøver å lindre angsten med alkohol eller illegale medikamenter, og dette er nok en viktig del av forklaringen på at hyppigheten av selvmord er økt blant de med generalisert angst. Det samme er risikoen for hjertesykdom - uavhengig av andre kjente risikofaktorer (som f.eks. økt blodtrykk) for slik sykdom.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Generalisert angstlidelse . Referanselisten for dette dokumentet vises nedenfor

  1. Hoge EA, Ivkovic A, Fricchione GL, Generalized anxiety disorder: diagnosis and treatment. BMJ 2012;345: e7500. www.bmj.com
  2. McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender Differences in Anxiety Disorders: Prevalence, Course of Illness, Comorbidity and Burden of Illness. J Psychiatr Res 2011; 45: 1027–35. pmid:21439576 PubMed
  3. Malt U, Andressen OA, Malt EA, Melle I, Årsland D (red). Lærebok i psykiatri. Oslo: Gyldendal akademisk, 2018.
  4. Pansepp J Affective neuroscience. The foundations of human and animal emotions. New York: Oxford University Press, USA, September 3, 2004; ISBN-13: 978-0195178050
  5. Nordahl HM, Borkovec TD, Hagen R, et al. Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder. BJPsych Open 2018; 4: 393-400. pmid:30294448 PubMed
  6. Fricchione G. Generalized anxiety disorder. N Engl J Med 2004; 351: 675-82. PubMed
  7. Simon NM, Blacker D, Korbly NB, et al. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord 2002; 69: 209-17. PubMed
  8. Aarre TF. En mindre medisinsk psykiatri. Oslo: Universitetsforlaget, 2018. tidsskriftet.no
  9. Nordmo E, Vorren S. Lyrica - norske bivirkningsmeldinger om misbruk. RELIS 2014.
  10. Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010 Dec;123(12):1087-90. PubMed
  11. Stein MB, Sareen J. Clinical Practice. Generalized Anxiety Disorder. N Engl J M. 2015; 373:2059-2068. pmid:26580998 PubMed
  12. Covin R, Ouimet AJ, Seeds PM, et al. A meta-analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord. 2008;22:108-116. PubMed
  13. Hendriks GJ, Oude Voshaar RC, Keijsers GP, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2008;117:403-411. PubMed
  14. Kriz S, Solberg B. Kognitiv atferdsterapi. Norsk barne- og ungdomspsykiatrisk forening, veileder i BUP. Publisert 07. juli 2017. legeforeningen.no
  15. Olthuis JV, Watt MC, Bailey K, et al. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016;(3):CD011565. Cochrane (DOI)
  16. Gosselin P, Ladouceur R, Morin CM, Dugas MJ, Baillargeon L. Benzodiazepine Discontinuation Among Adults With GAD: A Randomized Trial of Cognitive-Behavioral Therapy. J Consult Clin Psychol 2006; 74: 908-19. PubMed
  17. Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ 2011; 342: d1199. BMJ (DOI)
  18. Slee A, Nazareth I, Bondaronek P et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 2019; S0140-6736: 31793-8. pmid:30712879 PubMed
  19. Lenze EJ, Rollman BL, Shear K, et al. Escitalopram for older adults with generalized anxiety disorder. JAMA 2009; 301: 295-303. Journal of the American Medical Association
  20. Frampton J. Pregabalin: A review of its use in adults with generalized anxiety disorder. CNS Drugs 2014; 9: 835-54. pmid:25149863 PubMed
  21. Starcevic V. Anxiety states: a review of conceptual and treatment issues. Curr Opin Psychiatry 2006; 19: 79-83. PubMed
  22. Creswell C, Waite P, Cooper PJ, Assessment and management of anxiety disorders in children and adolescents. Arch Dis Child 2014;99: 674-678 PubMed
  23. Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med. 2010;170:321-331. PubMed
  24. Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004691. DOI: 10.1002/14651858.CD004691.pub2. DOI
  25. Stonerock GL, Hoffman BM, Smith PJ, et al. Exercise as Treatment for Anxiety: Systematic Review and Analysis. Ann Behav Med. 2015;49(4):542-56. PubMed
  26. Jorm AF, Christensen H, Griffiths KM, Parslow RA, Rodgers B, Blewitt KA. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: S29-46. PMID: 15462640 PubMed
  27. Parslow R, Morgan AJ, Allen NB. Effectiveness of complementary and self-help treatments for anxiety in children and adolescents. Med J Aust 2008; 188: 355-9. pmid:18341460 PubMed
  28. Ravindran AV, da Silva TL. Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review. J Affect Disord 2013; 150: 707-19. pmid:23769610 PubMed
  29. Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev. 2006; 1: CD004998. pmid:16437509 PubMed
  30. Robinson J, Biley FC, Dolk H. Therapeutic touch for anxiety disorders. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006240. DOI: 10.1002/14651858.CD006240.pub2. DOI
  31. Miyasaka LS, Atallah ÁN, Soares B. Passiflora for anxiety disorder. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD004518. DOI: 10.1002/14651858.CD004518.pub2. DOI
  32. Bruce SE, et al. Influence of psychiatric comorbidity on recovery and recurrence in generela anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-87. American Journal of Psychiatry
  33. DeMartini J, Patel G, Fancher TL. Generalized Anxiety Disorder. Ann Intern Med. 2019 Apr 2;170(7):ITC49-ITC64. PMID: 30934083. PubMed
  34. Feltner DE, Crockatt JG, Dubovsky SJ et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003; 23: 240-9. PubMed
  35. Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of Generalized Anxiety Disorder. Int J Neuropsychopharmacol 2005; 8: 293-302. PubMed
  36. Herr NR, Williams JW Jr, Benjamin S, et al. Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. JAMA. 2014 ;312(1):78-84. doi: 10.1001/jama.2014.5950 DOI
Annonse
Annonse